OpenAlex | P3.03I.06 Neoadjuvant Gefitinib in EGFR Mutated NSCLC (a Phase 2 Window-Of-Opportunity Study): Deep Genomic and Transcriptomic Analysis

P3.03I.06 Neoadjuvant Gefitinib in EGFR Mutated NSCLC (a Phase 2 Window-Of-Opportunity Study): Deep Genomic and Transcriptomic Analysis

Work

Year: 2024

Type: article

Source: Journal of Thoracic Oncology

Authors A.C. Tan, Jia-Chi Yeo, M. Pang, Jacob J.S. Alvarez, Aiying Guo +22 more

Cites:

Cited by:

Related to: 10

FWCI:

Citation percentile (by year/subfield):

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

Open Access status: closed